Statistics
Publications
43
Citations
2.3K
H-Index
28
Active since
1999
Inmaculada Rioja is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, bromodomain proteins, and bromodomain inhibition.
Publications per year
1999–2023
43
43
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 428 citations · Full text
Inmaculada Rioja, Fiona J. Hughes, Catriona Sharp et al. · Arthritis & Rheumatism · 2008 · 139 citations
Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells
Wenxian Fu, Júlia Farache, Susan M. Clardy et al. · eLife · 2014 · 86 citations · Full text
1–5 of 43